Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1955 1
1957 2
1961 1
1963 4
1964 8
1965 7
1966 3
1967 3
1968 6
1969 8
1970 18
1971 15
1972 9
1973 8
1974 13
1975 42
1976 18
1977 28
1978 25
1979 37
1980 35
1981 37
1982 52
1983 41
1984 54
1985 82
1986 60
1987 65
1988 76
1989 91
1990 94
1991 97
1992 101
1993 116
1994 117
1995 147
1996 157
1997 149
1998 166
1999 157
2000 161
2001 196
2002 229
2003 243
2004 231
2005 301
2006 346
2007 361
2008 334
2009 415
2010 473
2011 531
2012 551
2013 625
2014 642
2015 623
2016 686
2017 702
2018 775
2019 800
2020 961
2021 1011
2022 913
2023 899
2024 396

Text availability

Article attribute

Article type

Publication date

Search Results

13,535 results

Results by year

Filters applied: . Clear all
Page 1
Pathobiology and Diagnosis of Multiple Myeloma.
Brigle K, Rogers B. Brigle K, et al. Semin Oncol Nurs. 2017 Aug;33(3):225-236. doi: 10.1016/j.soncn.2017.05.012. Epub 2017 Jul 5. Semin Oncol Nurs. 2017. PMID: 28688533 Review.
OBJECTIVE: To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of multiple myeloma (MM). DATA SOURCES: Peer-reviewed articles and clinical guidelines. CONCLUSION: The acquisition of genetic chan …
OBJECTIVE: To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of …
Roadmap to cure multiple myeloma.
Rodriguez-Otero P, Paiva B, San-Miguel JF. Rodriguez-Otero P, et al. Cancer Treat Rev. 2021 Nov;100:102284. doi: 10.1016/j.ctrv.2021.102284. Epub 2021 Aug 31. Cancer Treat Rev. 2021. PMID: 34597912 Free article. Review.
Despite significant advances in the treatment of multiple myeloma which had led to unprecedented rates of response and survival, patients still relapse, and cure remains elusive. We propose in this review a roadmap to achieve the dream of cure for multiple …
Despite significant advances in the treatment of multiple myeloma which had led to unprecedented rates of response and surviva …
Multiple myeloma: Every year a new standard?
Rajkumar SV. Rajkumar SV. Hematol Oncol. 2019 Jun;37 Suppl 1(Suppl 1):62-65. doi: 10.1002/hon.2586. Hematol Oncol. 2019. PMID: 31187526 Free PMC article. Review.
This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Treatment approach for both newly diagnosed and relapsed disease are discussed....
This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Trea …
Non-secretory multiple myeloma: Diagnosis and management.
Charliński G, Jurczyszyn A. Charliński G, et al. Adv Clin Exp Med. 2022 Jan;31(1):95-100. doi: 10.17219/acem/141455. Adv Clin Exp Med. 2022. PMID: 34637200 Free article. Review.
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. ...
Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. ...
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.
Rajkumar SV. Rajkumar SV. Am Soc Clin Oncol Educ Book. 2016;35:e418-23. doi: 10.1200/EDBK_159009. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249749 Free article. Review.
There has been remarkable progress made in the diagnosis and treatment of multiple myeloma (MM). The median survival of the disease has doubled as a result of several new active drugs. ...
There has been remarkable progress made in the diagnosis and treatment of multiple myeloma (MM). The median survival of the di …
Smoldering multiple myeloma.
Rajkumar SV, Landgren O, Mateos MV. Rajkumar SV, et al. Blood. 2015 May 14;125(20):3069-75. doi: 10.1182/blood-2014-09-568899. Epub 2015 Apr 2. Blood. 2015. PMID: 25838344 Free PMC article. Review.
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM is distinguished from monoclonal gammopathy of undetermined significance by a much higher risk of progression to multiple myeloma (MM). There have been major advances …
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM is distinguished from monoclonal gammopa …
The Diagnosis and Treatment of Multiple Myeloma.
Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S. Gerecke C, et al. Dtsch Arztebl Int. 2016 Jul 11;113(27-28):470-6. doi: 10.3238/arztebl.2016.0470. Dtsch Arztebl Int. 2016. PMID: 27476706 Free PMC article. Review.
BACKGROUND: Multiple myeloma is a malignant disease of plasma cells with a worldwide incidence of 6-7 cases per 100 000 persons per year. ...CONCLUSION: Recent therapeutic advances have made the treatment of multiple myeloma both more complex and more …
BACKGROUND: Multiple myeloma is a malignant disease of plasma cells with a worldwide incidence of 6-7 cases per 100 000 person …
Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse.
Bhatt P, Kloock C, Comenzo R. Bhatt P, et al. Curr Oncol. 2023 Feb 15;30(2):2322-2347. doi: 10.3390/curroncol30020179. Curr Oncol. 2023. PMID: 36826140 Free PMC article. Review.
Multiple myeloma remains an incurable disease with the usual disease course requiring induction therapy, autologous stem cell transplantation for eligible patients, and long-term maintenance. ...In this broad scoping review of available therapies in relapsed/refract …
Multiple myeloma remains an incurable disease with the usual disease course requiring induction therapy, autologous stem cell …
Immunotherapy for the treatment of multiple myeloma.
Boussi LS, Avigan ZM, Rosenblatt J. Boussi LS, et al. Front Immunol. 2022 Oct 28;13:1027385. doi: 10.3389/fimmu.2022.1027385. eCollection 2022. Front Immunol. 2022. PMID: 36389674 Free PMC article. Review.
Despite advances in treatment for multiple myeloma, the majority of patients ultimately develop relapsed disease marked by immune evasion and resistance to standard therapy. ...
Despite advances in treatment for multiple myeloma, the majority of patients ultimately develop relapsed disease marked by imm …
Multiple Myeloma Genomics - A Concise Review.
Castaneda O, Baz R. Castaneda O, et al. Acta Med Acad. 2019 Apr;48(1):57-67. doi: 10.5644/ama2006-124.242. Acta Med Acad. 2019. PMID: 31264433 Free article. Review.
The aim of this review is to summarize the current knowledge of genomic information in multiple myeloma. Multiple myeloma is a genetically complex plasma cell neoplasm that evolves from pre-malignant stages following genomic evolution leading to the pr …
The aim of this review is to summarize the current knowledge of genomic information in multiple myeloma. Multiple my …
13,535 results
You have reached the last available page of results. Please see the User Guide for more information.